Psoriasis Stocks List

Psoriasis Stocks Recent News

Date Stock Title
May 13 ABBV AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
May 13 INCY Incyte Launches $1.67 Billion Share Repurchase 'Dutch Auction' Tender Offer; to Buy Back $328 Million of Baker Entities' Shares
May 13 INCY Incyte jumps 6%, intends to buy back $2B stock
May 13 ARQT Expert Panel Review Further Validates Use of ZORYVE® (roflumilast) Topical Foam, 0.3% for Treatment of Seborrheic Dermatitis Across Diverse Hair Types Published in Journal of Clinical and Aesthetic Dermatology
May 13 INCY Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock
May 12 INCY Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
May 11 ABBV 29 Huge Companies That You’ve Never Heard of Before and Their Stock Prices
May 11 ABBV Earn $1000 Every Month From These 3 Stocks
May 11 ABBV Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
May 10 ABBV Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
May 10 ABBV 3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
May 9 VTVT vTv Therapeutics GAAP EPS of -$1.17, revenue of $1M
May 9 VTVT vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
May 9 VYNE VYNE Therapeutics GAAP EPS of -$0.15 beats by $0.09, revenue of $0.01M misses by $0.09M
May 9 BDRX Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating Precancerous Condition
May 9 VYNE VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 ABBV Q1 2024 Regenxbio Inc Earnings Call
May 8 BIIB Jeff Auxier's Firm Dissolves Textainer Group Position, Trims Biogen
May 8 BIIB Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
May 8 ABBV QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults
Psoriasis

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, dry, itchy, and scaly. On people with darker skin the patches may be purple in colour. Psoriasis varies in severity from small, localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.There are five main types of psoriasis: plaque, guttate, inverse, pustular, and erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, makes up about 90 percent of cases. It typically presents as red patches with white scales on top. Areas of the body most commonly affected are the back of the forearms, shins, navel area, and scalp. Guttate psoriasis has drop-shaped lesions. Pustular psoriasis presents as small non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic psoriasis occurs when the rash becomes very widespread, and can develop from any of the other types. Fingernails and toenails are affected in most people with psoriasis at some point in time. This may include pits in the nails or changes in nail color.Psoriasis is generally thought to be a genetic disease that is triggered by environmental factors. In twin studies, identical twins are three times more likely to be affected compared to non-identical twins. This suggests that genetic factors predispose to psoriasis. Symptoms often worsen during winter and with certain medications, such as beta blockers or NSAIDs. Infections and psychological stress can also play a role. Psoriasis is not contagious. The underlying mechanism involves the immune system reacting to skin cells. Diagnosis is typically based on the signs and symptoms.There is no cure for psoriasis; however, various treatments can help control the symptoms. These treatments include steroid creams, vitamin D3 cream, ultraviolet light and immune system suppressing medications, such as methotrexate. About 75 percent of cases can be managed with creams alone. The disease affects two to four percent of the population. Men and women are affected with equal frequency. The disease may begin at any age, but typically starts in adulthood. Psoriasis is associated with an increased risk of psoriatic arthritis, lymphomas, cardiovascular disease, Crohn's disease and depression. Psoriatic arthritis affects up to 30 percent of individuals with psoriasis.

Browse All Tags